About this trial
Valvular heart disease (VHD) is a growing public health concern globally, with increasing disease burden and rising interest in advanced treatment strategies such as transcatheter interventions. However, there remains a significant lack of real-world data regarding echocardiography practices, disease prevalence and progression, referral patterns, and treatment pathways. Addressing these gaps is critical for improving patient care and informing clinical decision-making.
South Korea provides a unique opportunity to conduct a nationwide retrospective echocardiographic study due to its advanced healthcare infrastructure, high patient volume, and strong tradition in clinical research. The current study aims to evaluate the real-world burden and clinical journey of patients with moderate or severe valvular disease over a 10-year period, based on echocardiographic and electronic medical record (EMR) data collected from multiple tertiary centers across the country.
Eligibility criteria
Qualifiers
Period: 2010.1.1~2020.12.31
Age > 18 years
Moderate or severe native VHD (AS, AR, MR and TR)
Perform echocardiography more than twice
Disqualifiers
Poor image of echocardiography
Follow up loss
Trial design
Treatments tested in this trial
- Not listed